Home LiteratureArticle Details
PMID: 10751394 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Cholesterol movement in Niemann-Pick type C cells and in cells treated with amphiphiles.

The Journal of biological chemistry ·Vol. 275 ·No. 23 ·2000-06-09 ·Pages 17468-75

Lange Y, Ye J, Rigney M, Steck T

Abstract

Cholesterol accumulates to massive levels in cells from Niemann-Pick type C (NP-C) patients and in cells treated with class 2 amphiphiles that mimic NP-C disease. This behavior has been attributed to the failure of cholesterol released from ingested low density lipoproteins to exit the lysosomes. However, we now show that the rate of movement of cholesterol from lysosomes to plasma membranes in NP-C cells is at least as great as normal, as was also found previously for amphiphile-treated cells. Furthermore, the lysosomes in these cells filled with plasma membrane cholesterol in the absence of lipoproteins. In addition, we showed that the size of the endoplasmic reticulum cholesterol pool and the set point of the homeostatic sensor of cell cholesterol were approximately normal in NP-C cells. The plasma membrane cholesterol pools in both NP-C and amphiphile-treated cells were also normal. Furthermore, the build up of cholesterol in NP-C lysosomes was not a physiological response to cholesterol overload. Rather, it appeared that the accumulation in NP-C lysosomes results from an imbalance in the brisk flow of cholesterol among membrane compartments. In related experiments, we found that NP-C cells did not respond to class 2 amphiphiles (e.g. trifluoperazine, imipramine, and U18666A); these agents may therefore act directly on the NPC1 protein or on its pathway. Finally, we showed that the lysosomal cholesterol pool in NP-C cells was substantially and preferentially reduced by incubating cells with the oxysterols, 25-hydroxycholesterol and 7-ketocholesterol; these findings suggest a new pharmacological approach to the treatment of NP-C disease.

MeSH Terms
Androstenes/pharmacology Anticholesteremic Agents/pharmacology Cell Line Cell Membrane/metabolism Cells, Cultured Cholesterol/metabolism Culture Media Endoplasmic Reticulum/metabolism Fibroblasts/drug effects,metabolism Homeostasis Humans Imipramine/pharmacology Kinetics Lipoproteins/physiology Lysosomes/metabolism Membrane Lipids/metabolism Monensin/pharmacology Niemann-Pick Diseases/metabolism,pathology Skin/metabolism Trifluoperazine/pharmacology
Chemicals
Androstenes Anticholesteremic Agents Culture Media Lipoproteins Membrane Lipids Trifluoperazine 3-beta-(2-(diethylamino)ethoxy)androst-5-en-17-one Monensin Cholesterol Imipramine
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lange Y
Department of Pathology, Rush-Presbyterian-St. Luke's Medical Center University of Chicago, Chicago, Illinois 60637, USA. [email protected]
Ye J
Rigney M
Steck T
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2000-06-09
Pages
17468-75
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]